• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Now accepting nominations for the Fierce Innovation Awards - Submit your application today

Clinical Data

The latest clinical trial data, study results, and research findings shaping drug development decisions across the pharmaceutical industry.

Coral shaped like brain sitting on ocean beach
Biotech

Definium hits another ph. 3 homerun with anxiety ‘sea change’

The 214-patient Voyage trial pitted a psychoactive session with Definium’s DT120 ODT against placebo, with the psychedelic coming out ahead.
Darren Incorvaia Aug 12, 2026 7:00am
failure crash no fail rocket cancelled end

Sionna’s cystic fibrosis flop a ‘significant’ boost for Vertex

Aug 10, 2026 9:38am
Graphic image of an arrow nailing the bullseye of a target

AbCellera tops ‘most aggressive’ hopes, putting rivals on notice

Aug 10, 2026 8:24am
red blood cells

Silence brings the noise to Takeda with phase 2 blood cancer win

Aug 10, 2026 7:31am
Microphone on stage

Double shot of Vistagen’s anxiety nasal spray misses in ph. 2

Aug 6, 2026 10:32am
visual of neurons under Parkinsons disease

BioVie stock halves on Parkinson’s phase 2 readout

Aug 6, 2026 9:40am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings